myclausen
passauer pharma gmbh - mofetilmikofenolat - zavrnitev presadka - imunosupresivi - myclausen je indiciran v kombinaciji s ciklosporinom in kortikosteroidi za profilakso akutne zavrnitve presadka pri bolnikih, ki so prejemali alogenske ledvične, srčne ali jetrne presaditve.
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinalni stromalni tumorji - antineoplastična sredstva - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.
jaypirca
eli lilly nederland b.v. - pirtobrutinib - limfom, mantle cell - proteinska kinaza inhibitorji - treatment of mantle cell lymphoma (mcl).
ketoconazole hra
hra pharma rare diseases - ketokonazol - cushingov sindrom - antimikotiki za sistemsko uporabo - ketokonazol hra je indiciran za zdravljenje endogenega cushingovega sindroma pri odraslih in mladostnikih, starejših od 12 let.
inrebic
bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastična sredstva - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.
cibinqo
pfizer europe ma eeig - abrocitinib - dermatitis, atopic - drugi dermatološki preparati - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.
invirase
roche registration gmbh - sakvinavir - okužbe z virusom hiv - antivirusi za sistemsko uporabo - zdravilo invirase je indicirano za zdravljenje odraslih bolnikov s hiv-1. zdravilo invirase se lahko daje le v kombinaciji z ritonavirjem in drugimi protiretrovirusnimi zdravili.
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemija, myeloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.
ceplene
laboratoires delbert - histamin dihydrochloride - leukemija, myeloid, akutna - immunostimulants, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). učinkovitost zdravila ceplene ni bila v celoti dokazana pri bolnikih, starejših od 60 let.
hexvix 85 mg prašek in vehikel za intravezikalno raztopino
ipsen pharma - heksaminolevulinat - prašek in vehikel za intravezikalno raztopino - heksaminolevulinat 85 mg / 1 viala - heksaminolevulinat